# OnCo record nct02264678 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02264678/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02264678", "NCT02264678" ;
  schema:name "Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents"@en ;
  schema:description "This study tests a PARP inhibitor; the registry reports that it is active not recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02264678/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02264678> ;
  onco:status "active" ;
  onco:phase "1" ;
  schema:startDate "2014-10-31" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/saruparib/> .
